• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Context Therapeutics Inc. (CNTX) Latest News

Context Therapeutics Inc. (CNTX) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price

$1.40

-$0.1

(-6.67%)

Day's range
$1.27
Day's range
$1.43

Latest News of CNTX

Context Therapeutics Inc.'s (NASDAQ:CNTX) top owners are individual investors with 52% stake, while 30% is held by private equity firms

By Yahoo! Finance | 3 months ago

Ownership data of Context Therapeutics Inc. reveals that individual investors own 52%, private equity firms own 30%, and institutional investors hold a significant stake. Analyst forecasts and ownersh...

CNTX Stock Price | Context Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

By MarketWatch | 4 months ago

Context Therapeutics, Inc. is focused on developing innovative treatments for hormone-driven breast and gynecological cancers. Their lead candidate, ONA-XR, aims to be a complete antagonist of the pro...

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.